Immunome - Oncology Is Hot
January 10, 2024 at 17:44 PM EST
Immunome, an oncology biomedical company, has gained 27.48% since a buy signal on December 22.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.